Summary
We have studied the influence of multiple oral doses of cholestyramine on the single dose pharmacokinetics of tenoxicam and piroxicam in eight healthy young volunteers.
Each subject received on two occasions single intravenous injections of 20 mg tenoxicam and on another two occasions single oral doses of 20 mg piroxicam. Both medications were followed by multiple oral doses of either cholestyramine or plain water (placebo).
Compared with placebo cholestyramine accelerated the elimination of both drugs. The average values of half-lives were reduced (tenoxicam: 31.9 h vs 67.4 h; piroxicam: 28.1 h vs 46.8 h) due to increases in clearance. Cholestyramine-mediated enhancement of drug elimination was most pronounced in the subjects with a comparatively low baseline drug clearance. Thus, intersubject variability in clearance was smaller when the drug administrations were followed by the anion-exchange resin.
The twofold acceleration of tenoxicam elimination in the present study in man contrasts with a much larger effect (five-fold) seen in experiments with dogs. This points to a much easier access of unchanged tenoxicam to the intestinal lumen in the dogs than in man.
Comparing the pharmacokinetics of tenoxicam and piroxicam in the same volunteers revealed a high degree of correlation in clearance and half-lives and similar intersubject variabilities in mean kinetic variables.
Similar content being viewed by others
References
Berlinger WG, Spector R, Goldberg MJ, Johnson GF, Quee CK, Berg MJ (1983) Enhancement of theophylline clearance by oral activated charcoal. Clin Pharmacol Ther 33: 351–354
Boylan JJ, Cohn WJ, Egle JL, Blanke RV, Guzelian PS (1979) Excretion of chlordecone by the gastrointestinal tract: Evidence for a nonbiliary mechanism. Clin Pharmacol Ther 25: 579–585
Caldwell JH, Caldwell PB, Murphy JW, Beachler CW (1980) Intestinal secretion of digoxin in the rat. Naunyn Schmiedebergs Arch Pharmacol 312: 271–275
Crevoisier C, Heizmann P (1986) Pharmacokinetics of tenoxicam. EULAR Lit Rheum 5: 7–14
Dujovne CA, Gustafson JA, Dickey RA (1982) Suitable method for quantitation of biliary excretion of drugs in humans. Clin Pharmacol Ther 31: 187–194
Edwards IR, Ferry DG, Campbell JA (1985) Factors affecting the kinetics of two benzothiazine non-steroidal anti-inflammatory medicines, piroxicam and isoxicam. Eur J Clin Pharmacol 28: 689–692
Fourtillan JB (1983) La pharmacocinétique du piroxicam (Feldene) chez l'homme. Rhumatologie 35: 11–16
Gibaldi M, Perrier D (1982) Pharmacokinetics. Dekker, New York, Basel
Guentert TW, Schmitt M, Defoin R (1986) Acceleration of the elimination of tenoxicam by cholestyramine in the dog. J Pharmacol Exp Ther 238: 295–301
Heintz RC, Guentert TW, Enrico JF, Dubach UC, Brandt R, Jeunet FS (1984) Pharmacokinetics of tenoxicam in healthy human volunteers. Eur J Rheumatol Inflamm 7: 33–44
Heizmann P, Körner J, Zinapold K (1986) Determination of tenoxicam in human plasma by HPLC. J Chromatogr 374: 95–102
Hobbs DC (1983) Pharmacokinetics of piroxicam in man. Eur J Rheumatol Inflamm 6: 46–55
Hobbs DC (1986) Piroxicam pharmacokinetics: Recent clinical results relating kinetics and plasma levels to age, sex, and adverse effects. Am J Med 81 [Suppl 5B]: 22–28
Israili ZH, Dayton PG (1984) Enhancement of xenobiotic elimination: Role of intestinal excretion. Drug Metab Rev 15: 1123–1159
Laufen H, Leitold M, Riederl KD (1984) The effect of activated charcoal on the gastrointestinal absorption and reabsorption of piroxicam in dog and man (abstracts p 356). 2nd European Congress of Biopharmaceutics and Pharmacokinetics, Salamanca
Levy G (1982) Gastrointestinal clearance of drugs with activated charcoal. N Engl J Med 307: 676–678
Riegelman S, Collier P (1980) The application of statistical moment theory to the evaluation of in vivo dissolution time and absorption time. J Pharmacokinet Biopharm 8: 509–534
Schiantarelli P, Acerbi D, Bovis G (1981) Some pharmacokinetic properties and bioavailability by oral and rectal route of piroxicam in rodents and man. Arzneimittelforsch/Drug Res 31: 92–97
Soloway RD, Carlson HC, Schoenfield LJ (1972) A balloon-occludable T-tube for cholangiography and quantitative collection and reinfusion of bile in man. J Lab Clin Med 79: 500–504
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Guentert, T.W., Defoin, R. & Mosberg, H. The influence of cholestyramine on the elimination of tenoxicam and piroxicam. Eur J Clin Pharmacol 34, 283–289 (1988). https://doi.org/10.1007/BF00540957
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00540957